Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 18/20 | 0.54 |
| ▸ | MAP2K2 | P36507 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5554721 | 0.89 | MAP2K1 (0.42) | MAP2K1MAP2K2KMT2A | |
| SCHEMBL1821414 | 0.83 | MAP2K1 (0.46) | MAP2K1MAP2K2KMT2A | |
| SCHEMBL5554834 | 0.78 | MAP2K1 (0.45) | MAP2K1MAP2K2 | |
| SCHEMBL4228378 | 0.75 | MAP2K1 (0.50) | MAP2K1MAP2K2 | |
| SCHEMBL27883682 | 0.74 | MAP2K1 (0.56) | MAP2K1MAP2K2 | |
| SCHEMBL12540652 | 0.73 | MAP2K1 (0.47) | MAP2K1MAP2K2 | |
| SCHEMBL5559369 | 0.72 | MAP2K1 (0.44) | MAP2K1MAP2K2KMT2A | |
| SCHEMBL30185614 | 0.71 | MAP2K1 (0.71) | MAP2K1MAP2K2DGAT1 | |
| SCHEMBL1022810 | 0.71 | MAP2K1 (0.52) | MAP2K1MAP2K2KMT2A | |
| SCHEMBL12095333 | 0.70 | MAP2K1 (0.49) | MAP2K1MAP2K2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1682138-A4 | HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF | ARRAY BIOPHARMA INC (US) | 2007-01-24 | — | — | EP | disclosed |
| EP-1682138-A2 | HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF | Array Biopharma, Inc. (US) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005051301-A2 | HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF | ARRAY BIOPHARMA INC. (US) | 2005-06-09 | — | — | WO | disclosed |